Recent advances of basal cell carcinoma, squamous cell carcinoma, and carcinoma in situ
10.5124/jkma.2018.61.11.655
- Author:
Kun PARK
1
Author Information
1. Department of Dermatology, Wonkwang University School of Medicine, Iksan, Korea. derma@chol.com
- Publication Type:Original Article
- Keywords:
Carcinoma, basal cell;
Carcinoma, squamous cell;
Bowen's disease;
Erythroplasia of Queyrat;
Treatment
- MeSH:
Bowen's Disease;
Carcinoma in Situ;
Carcinoma, Basal Cell;
Carcinoma, Squamous Cell;
Dermoscopy;
Diagnosis;
Epithelial Cells;
Erythroplasia;
Hedgehogs;
Humans;
Incidence;
Japan;
Korea;
Prognosis;
Sentinel Lymph Node Biopsy;
Skin;
Solar System
- From:Journal of the Korean Medical Association
2018;61(11):655-661
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Incidence of basal and squamous cell carcinoma is increasing among Korean. With increasing this incidence we need to attend the management and prevention of these cutaneous malignancies. Basal cell carcinoma (BCC) is the most common skin malignancy. Sun exposure is the most important environmental cause of BCC. Daily sun protection especially avoiding sun exposure between 10 a.m. and 4 p.m. provides most effective prevention against chronic ultraviolet-induced skin damage. Hedgehog pathway inhibitors are used locally advanced and metastatic BCC lesions in Korea. Until recently, there are no reports whether it developed resistance of Hedgehog pathway inhibitors with advanced BCC in Korean patients. Among malignant skin tumors, 19.1% were squamous cell carcinoma (SCC). The incidence of SCC was rapidly increased over the past years. However, the incidence rate of SCC in Japan has not been changed from the period 1976–1980 to 1986–1990. Sentinel lymph node biopsy for SCC did not provide diagnostic value. Bowen's disease and Erythroplasia of Queyrat are considered as carcinoma in situ of the skin. Erythroplasia of Queyrat have worse prognosis with a higher rate of malignant degeneration. Dermoscopy may helpful tool in assisting the noninvasive diagnosis of carcinoma in situ of the skin.
